Endoglin is not critical for hematopoietic stem cell engraftment and reconstitution but regulates adult erythroid development

Stem Cells

Volumn 25, Issue 11, 2007, Pages 2809-2819

  Moody, Jennifer L ^a   Singbrant, Sofie ^a   Karlsson, Göran ^a   Blank, Ulrika ^a   Aspling, Marie ^a   Flygare, Johan ^a   Bryder, David ^b   Karlsson, Stefan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Erythropoiesis; Hematopoiesis; RNA interference; Stem cells

Indexed keywords

ENDOGLIN; LENTIVIRUS VECTOR; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASOPHIL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL TRANSPLANTATION; CLONOGENESIS; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOLOGY; ERYTHROBLAST; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; LEUKOCYTE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; THROMBOCYTE;

AGING; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ERYTHROPOIESIS; HELA CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NIH 3T3 CELLS;

EID: 36249002298     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0602     Document Type: Article

References (53)

1. Chen CZ, Li M, de Graaf D et al. Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci U S A 2002;99:15468-15473.
2. Ivanova NB, Dimos JT, Schaniel C et al. A stem cell molecular signature. Science 2002;298:601-604.
3. Kiel MJ, Yilmaz OH, Iwashita T et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005;121:1109-1121.
4. Chen CZ, Li L, Li M et al. The endoglin(positive) sca-1(positive) rhodamine(low) phenotype defines a near-homogeneous population of long-term repopulating hematopoietic stem cells. Immunity 2003;19:525-533.
5. Larsson J, Karlsson S. The role of Smad signaling in hematopoiesis. Oncogene 2005;24:5676-5692.
6. Ruscetti FW, Akel S, Bartelmez SH. Autocrine transforming growth factor-beta regulation of hematopoiesis: Many outcomes that depend on the context. Oncogene 2005;24:5751-5763.
7. Fonsatti E, Del Vecchio L, Altomonte M et al. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol 2001;188:1-7.
8. Lebrin F, Goumans MJ, Jonker L et al. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J 2004;23:4018-4028.
9. Blanco FJ, Santibanez JF, Guerrero-Esteo M et al. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol 2005;204:574-584.
10. Pece-Barbara N, Vera S, Kathirkamathamby K et al. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway. J Biol Chem 2005;280:27800-27808.
11. Rokhlin OW, Cohen MB, Kubagawa H et al. Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J Immunol 1995;154:4456-4465.
12. Buhring HJ, Muller CA, Letarte M et al. Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow. Leukemia 1991;5:841-847.
13. Pierelli L, Scambia G, Bonanno G et al. CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/-precursors. Br J Haematol 2000;108:610-620.
14. Lastres P, Bellon T, Cabanas C et al. Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol 1992;22:393-397.
15. Schmidt-Weber CB, Letarte M, Kunzmann S et al. TGF-beta signaling of human T cells is modulated by the ancillary TGF-beta receptor endoglin. Int Immunol 2005;17:921-930.
16. Li DY, Sorensen LK, Brooke BS et al. Defective angiogenesis in mice lacking endoglin. Science 1999;284:1534-1537.
17. Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 1999;104:1343-1351.
18. Arthur HM, Ure J, Smith AJ et al. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 2000;217:42-53.
19. Cho SK, Bourdeau A, Letarte M et al. Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors. Blood 2001;98:3635-3642.
20. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: Lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003;77:8957-8961.
21. Hawley RG, Lieu FH, Fong AZ et al. Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1994;1:136-138.
22. Antonchuk J, Sauvageau G, Humphries RK. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Exp Hematol 2001;29:1125-1134.
23. Flygare J, Kiefer T, Miyake K et al. Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia. Blood 2005;105:4627-4634.
24. Miyake N, Brun AC, Magnusson M et al. HOXB4-induced self-renewal of hematopoietic stem cells is significantly enhanced by p21 deficiency. STEM CELLS 2006;24:653-661.
25. Utsugisawa T, Moody JL, Aspling M et al. A road map toward defining the role of Smad signaling in hematopoietic stem cells. STEM CELLS 2006;24:1128-1136.
26. Osawa M, Hanada K, Hamada H et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242-245.
27. Yang L, Bryder D, Adolfsson J et al. Identification of Lin(-)Sca1(+)kit(+) CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 2005;105:2717-2723.
28. Bradford GB, Williams B, Rossi R et al. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol 1997;25:445-453.
29. Wright DE, Cheshier SH, Wagers AJ et al. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood 2001;97:2278-2285.
30. Perez-Gomez E, Eleno N, Lopez-Novoa JM et al. Characterization of murine S-endoglin isoform and its effects on tumor development. Oncogene 2005;24:4450-4461.
31. Lastres P, Letamendia A, Zhang H et al. Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol 1996;133:1109-1121.
32. Li C, Hampson IN, Hampson L et al. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J 2000;14:55-64.
33. Ploemacher RE, van Soest PL, Boudewijn A. Autocrine transforming growth factor beta 1 blocks colony formation and progenitor cell generation by hemopoietic stem cells stimulated with steel factor. STEM CELLS 1993;11:336-347.
34. Keller JR, Mantel C, Sing GK et al. Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J Exp Med 1988;168:737-750.
35. Manning KL, McDonald TP. C3H mice have larger spleens, lower platelet counts, and shorter platelet lifespans than C57BL mice: An animal model for the study of hypersplenism. Exp Hematol 1997;25:1019-1024.
36. Forster I, Rajewsky K. The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow. Proc Natl Acad Sci U S A 1990;87:4781-4784.
37. Nanda N, Andre P, Bao M et al. Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling. Blood 2005;106:3028-3034.
38. Zhang J, Socolovsky M, Gross AW et al. Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: Functional analysis by a flow cytometry-based novel culture system. Blood 2003;102:3938-3946.
39. Blank U, Karlsson G, Moody JL et al. Smad7 promotes self-renewal of hematopoietic stem cells. Blood 2006;108:4246-4254.
40. Stier S, Cheng T, Dombkowski D et al. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 2002;99:2369-2378.
41. Reya T, Duncan AW, Ailles L et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003;423:409-414.
42. Balazs AB, Fabian AJ, Esmon CT et al. Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. Blood 2006;107:2317-2321.
43. Matsubara A, Iwama A, Yamazaki S et al. Endomucin, a CD34-like sialomucin, marks hematopoietic stem cells throughout development. J Exp Med 2005;202:1483-1492.
44. Jaffredo T, Nottingham W, Liddiard K et al. From hemangioblast to hematopoietic stem cell: An endothelial connection? Exp Hematol 2005;33:1029-1040.
45. Sanchez-Elsner T, Botella LM, Velasco B et al. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem 2002;277:43799-43808.
46. Li C, Issa R, Kumar P et al. CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 2003;116:2677-2685.
47. Lord BI. The architecture of bone marrow cell populations. In: Murphy MJ, ed. Concise Reviews in Clinical and Experimental Haematology. Dayton, OH: AlphaMed Press, 1992. p. 225-234.
48. Sanz-Rodriguez F, Guerrero-Esteo M, Botella LM et al. Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins. J Biol Chem 2004;279:32858-32868.
49. Conley BA, Koleva R, Smith JD et al. Endoglin controls cell migration and composition of focal adhesions: Function of the cytosolic domain. J Biol Chem 2004;279:27440-27449.
50. Larsson J, Blank U, Helgadottir H et al. TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. Blood 2003;102:3129-3135.
51. Larsson J, Goumans MJ, Sjostrand LJ et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J 2001;20:1663-1673.
52. Chang H, Huylebroeck D, Verschueren K et al. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 1999;126:1631-1642.
53. Oshima M, Oshima H, Taketo MM. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 1996;179:297-302.